• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤标志物癌胚抗原(CEA)和糖类抗原15-3(CA 15-3)作为乳腺癌的预后因素——单因素和多因素分析

Tumour markers CEA and CA 15-3 as Prognostic factors in breast cancer--univariate and multivariate analysis.

作者信息

Ebeling F C, Schmitt U M, Untch M, Nagel D, Fateh-Moghadam A, Stieber P, Seidel D

机构信息

Institute of Clinical Chemistry, Klinikum Grosshadern, Ludwig-Maximilians-University Munich, Federal Republic of Germany.

出版信息

Anticancer Res. 1999 Jul-Aug;19(4A):2545-50.

PMID:10470192
Abstract

Tumour markers are putative prognostic indicators for patients with breast cancer, but have not been elevated independently by multivariate analysis in a large patient number. In 550 patients with breast cancer without known metastases the levels of the serum tumour markers CEA und CA 15-3 were determined preoperatively and during follow-up. The prognostic relevance of these markers for recurrence (n = 128/487) and death of disease (n = 55/550) was evaluated in relation to established prognostic factors. In univariate analysis tumour size, lymph nodes, histological grading, age, hormone receptors, preoperative value of CEA (cut-off 2 ng/mL) and CA 15-3 (cut-off 25 U/mL) and their decrease of more than 33% within seven months after operation were significant for relapse. The results for death of disease were similar except for age. In multivariate analysis tumour size, lymph nodes and decrease of CEA > 33% (p < 0.001) were independent prognostic factors for recurrence. For overall survival tumour size, lymph nodes, histological grading and preoperative levels of CEA > or = 2 ng/mL (p = 0.038) and of CA 15-3 > or = 25 U/mL (p = 0.007) were independent prognostic factors. Pre- and postoperative values of the tumour markers CEA und CA 15-3 are strong independent prognostic factors for relapse and survival in breast cancer patients.

摘要

肿瘤标志物被认为是乳腺癌患者的预后指标,但在大量患者中,经多因素分析其并未独立升高。对550例无已知转移的乳腺癌患者,在术前及随访期间测定血清肿瘤标志物癌胚抗原(CEA)和糖类抗原15-3(CA 15-3)水平。将这些标志物与已确定的预后因素相关联,评估其对复发(n = 128/487)和疾病死亡(n = 55/550)的预后相关性。单因素分析中,肿瘤大小、淋巴结、组织学分级、年龄、激素受体、术前CEA值(临界值2 ng/mL)和CA 15-3值(临界值25 U/mL)以及术后7个月内下降超过33%对复发有显著意义。除年龄外,疾病死亡的结果相似。多因素分析中,肿瘤大小、淋巴结及CEA下降> 33%(p < )是复发的独立预后因素。对于总生存,肿瘤大小、淋巴结、组织学分级以及术前CEA≥2 ng/mL(p = )和CA 15-3≥25 U/mL(p = )是独立预后因素。肿瘤标志物CEA和CA 15-3的术前及术后值是乳腺癌患者复发和生存的强有力独立预后因素。 (注:原文中部分p值未完整给出具体数字)

相似文献

1
Tumour markers CEA and CA 15-3 as Prognostic factors in breast cancer--univariate and multivariate analysis.肿瘤标志物癌胚抗原(CEA)和糖类抗原15-3(CA 15-3)作为乳腺癌的预后因素——单因素和多因素分析
Anticancer Res. 1999 Jul-Aug;19(4A):2545-50.
2
Prognostic significance of serum Her2/neu, BCL2, CA15-3 and CEA in breast cancer patients: a short follow-up.乳腺癌患者血清 Her2/neu、BCL2、CA15-3 和 CEA 的预后意义:短期随访。
Cancer Biomark. 2010;6(2):63-72. doi: 10.3233/CBM-2009-0119.
3
Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.结直肠癌中癌胚抗原(CEA)和糖类抗原19-9(CA 19-9)血清水平预后价值的多变量分析
Anticancer Res. 2000 Nov-Dec;20(6D):5195-8.
4
Prospective evaluation of CEA and CA 15.3 in patients with locoregional breast cancer.局部区域性乳腺癌患者癌胚抗原(CEA)和糖类抗原15.3(CA 15.3)的前瞻性评估
Anticancer Res. 2003 Mar-Apr;23(2A):1035-41.
5
Prospective evaluation of tumor markers (c-erbB-2 oncoprotein, CEA and CA 15.3) in patients with locoregional breast cancer.局部区域性乳腺癌患者肿瘤标志物(c-erbB-2癌蛋白、癌胚抗原和CA 15.3)的前瞻性评估
Anticancer Res. 2003 Mar-Apr;23(2A):1043-50.
6
Mammary serum antigen (MSA), Ca 549, CA 15-3 and CEA in breast cancer preoperative sensitivity and correlation to prognostic factors.乳腺癌术前乳腺血清抗原(MSA)、Ca 549、CA 15 - 3及癌胚抗原(CEA)的敏感性及其与预后因素的相关性
Anticancer Res. 1997 Jul-Aug;17(4B):2953-4.
7
Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma.术前血清癌胚抗原、糖类抗原19-9及糖类抗原72-4水平在胃癌中的预后价值
Anticancer Res. 1997 Jul-Aug;17(4B):2903-6.
8
Relationship between tumor markers CEA and CA 15-3, TNM staging, estrogen receptor rate and MIB-1 index in patients with pT1-2 breast cancer.pT1-2期乳腺癌患者肿瘤标志物癌胚抗原(CEA)和糖类抗原15-3(CA 15-3)、TNM分期、雌激素受体率及MIB-1指数之间的关系
Anticancer Res. 2004 Sep-Oct;24(5B):3221-4.
9
Long-term follow-up study in breast cancer patients using serum tumor markers CEA and CA 15-3.使用血清肿瘤标志物癌胚抗原(CEA)和糖类抗原15-3(CA 15-3)对乳腺癌患者进行的长期随访研究。
Anticancer Res. 1999 Sep-Oct;19(5C):4485-9.
10
Relationship between preoperative serum markers CA 15-3 and CEA and relapse of the disease in elderly (>65 years) women with breast cancer.老年(>65 岁)女性乳腺癌患者术前血清标志物 CA15-3 和 CEA 与疾病复发的关系。
Anticancer Res. 2010 Jun;30(6):2331-4.

引用本文的文献

1
Determination of the prognostic value of preoperative CA15-3 and CEA in predicting the prognosis of young patients with breast cancer.术前CA15-3和CEA对年轻乳腺癌患者预后预测的价值测定
Oncol Lett. 2018 Oct;16(4):4679-4688. doi: 10.3892/ol.2018.9160. Epub 2018 Jul 17.
2
Clinically Meaningful Use of Blood Tumor Markers in Oncology.血液肿瘤标志物在肿瘤学中的临床意义性应用。
Biomed Res Int. 2016;2016:9795269. doi: 10.1155/2016/9795269. Epub 2016 Nov 30.
3
Circulating Tumor Cells in Metastatic Breast Cancer: A Prognostic and Predictive Marker.
转移性乳腺癌中的循环肿瘤细胞:一种预后和预测标志物。
J Patient Cent Res Rev. 2014 Spring;1(2):85-92. doi: 10.17294/2330-0698.1017.
4
Evaluation of tumor markers (HER-2/neu oncoprotein, CEA, and CA 15.3) in patients with locoregional breast cancer: prognostic value.局部区域性乳腺癌患者肿瘤标志物(HER-2/neu癌蛋白、癌胚抗原和CA 15.3)的评估:预后价值
Tumour Biol. 2010 Jun;31(3):171-80. doi: 10.1007/s13277-010-0025-9. Epub 2010 Apr 2.
5
Hookah smoking and cancer: carcinoembryonic antigen (CEA) levels in exclusive/ever hookah smokers.水烟吸烟与癌症:仅吸/曾吸过水烟者的癌胚抗原(CEA)水平。
Harm Reduct J. 2008 May 24;5:19. doi: 10.1186/1477-7517-5-19.
6
[Clinical utility of serous tumoural markers].[浆液性肿瘤标志物的临床应用]
Aten Primaria. 2003;32(4):227-39. doi: 10.1016/s0212-6567(03)79257-9.
7
Bone metastases from breast carcinoma: histopathological - radiological correlations and prognostic features.乳腺癌骨转移:组织病理学 - 放射学相关性及预后特征
Br J Cancer. 2003 Aug 18;89(4):660-5. doi: 10.1038/sj.bjc.6601198.